Advertisement

Lower Genital Tract Infections

  • David A. Eschenbach
Part of the Clinical Perspectives in Obstetrics and Gynecology book series (CPOG)

Abstract

For sexually active adult women, lower genital tract infections are one of the most frequent reasons to seek medical care. In 1971 an estimated 10.8 million women-visits were made because of vaginitis and cervicitis.1 Few women have not had at least one vaginal infection while a substantial number of women have difficulty with persistent or frequently recurrent symptoms. Although the absolute prevalence and the relative proportion of infectious vaginitis vary, depending on the population, there are three major causes of vaginitis: bacterial vaginosis, formerly called nonspecific vaginitis (40–50%), candidiasis (20–30%), and trichomoniasis (20–30%).2 An additional 5% of women have vaginitis that has not been well characterized. The number of women who complain of a vaginal discharge caused by cervicitis has not been well studied,3 but cervicitis is grossly underdiagnosed, and the addition of cervicitis to these data would further serve to emphasize the importance of lower genital tract infection.

Keywords

Obstet Gynecol Bacterial Vaginosis Genital Wart Vaginal Discharge Vaginal Candidiasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    National Disease and Therapeutic Index. Ambler, Pa.: Lea, 1971: 13–15.Google Scholar
  2. 2.
    Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis. Am J Obstet Gynecol. 1955; 69: 962–976.PubMedGoogle Scholar
  3. 3.
    Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis: the ignored counterpart in women of urethritis in men. N Engl J Med. 1984; 311: 1–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Huggins GR, Preti G. Vaginal odors and secretions. Clin Obstet Gynecol. 1981; 24: 355–377.PubMedCrossRefGoogle Scholar
  5. 5.
    Huggins GR, Preti G: Volatile constituents of human vaginal secretions. Am J Obstet Gynecol. 1976; 126: 129–136.PubMedGoogle Scholar
  6. 6.
    Hammerschlag M, Alpert S, Onderdonk AB, et al. Anaerobic microflora of the vagina in children. Am J Obstet Gynecol. 1978; 131: 853–856.PubMedGoogle Scholar
  7. 7.
    Bartlett JG, Moon NE, Goldstein PR, et al. Cervical and vaginal bacterial flora: ecologic niches in the female lower genital tract. Am J Obstet Gynecol. 1978; 130: 658–661.PubMedGoogle Scholar
  8. 8.
    Moghissi KS, Syner FN, Evans TN. A composite picture of the menstrual cycle. Am J Obstet Gynecol. 1972; 114: 405–416.PubMedGoogle Scholar
  9. 9.
    Levison ME, Corman LC, Carrington ER, et al. Quantitative bacteriology of the vaginal flora in vaginitis. Am J Obstet Gynecol. 1979; 133: 139–144.PubMedGoogle Scholar
  10. 10.
    Gorbach SL, Menda KB, Thadepalli H, et al. Anaerobic microflora of the cervix in healthy women. Am J Obstet Gynecol. 1973; 117: 1053–1055.PubMedGoogle Scholar
  11. 11.
    Larson B, Galask RP: Vaginal microbial flora: practical and theoretical relevance. Obstet Gynecol 1980; 55: 100S–113S.Google Scholar
  12. 12.
    Hill GB, Eschenbach DA, Holmes KK: Bacteriology of the vagina. In: Mardh PA, Taylor-Robinson D, eds. Bacterial vaginosis Stockholm: Almqvist and Wiksell, 1984; p 23.Google Scholar
  13. 13.
    McCormack WM, Rosner B, Lee Y-H. Colonization with genital mycoplasmas in women. Am J Epidemiol. 1973; 97: 240–245.PubMedGoogle Scholar
  14. 14.
    Chen KCS, Forsyth PS, Buchanan TM, et al. Amine content of vaginal fluid from untreated patients with nonspecific vaginitis. J Clin Invest. 1979; 63: 828–835.PubMedCrossRefGoogle Scholar
  15. 15.
    Singer RE, Buchner BA. Butyrate and propionate: important components of toxic dental placque extracts. Infect Immun. 1981; 32: 458–463.PubMedGoogle Scholar
  16. 16.
    McLennon MT, Smith JM, McClennon CE. Diagnosis of vaginal mycosis, trichomoniasis. Reliability of cytologic smear, wet smear and culture. Obstet Gynecol. 1972; 40: 231–234.Google Scholar
  17. 17.
    Smith RF, Rogers HA, Hines PA, et al. Comparison between direct microscopic and cultural methods of recognition of Corynebacterium vaginale in women with vaginitis. J Clin Microbiol. 1977; 5: 268–272.PubMedGoogle Scholar
  18. 18.
    Pheifer TA, Forsyth PA, Durfee MA, et al. Non-specific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med. 1978; 298: 1429–1434.PubMedCrossRefGoogle Scholar
  19. 19.
    Spiegel CA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol. 1983; 18: 170–177.PubMedGoogle Scholar
  20. 20.
    Eddie DAS. The laboratory diagnosis of vaginal infection caused by Trichomonas and Candida (Monilia) species. J Med Microbiol. 1968; 1: 153–156.PubMedCrossRefGoogle Scholar
  21. 21.
    Nielsen R. Trichomonas vaginalis. II. Laboratory investigation in trichomoniasis. Br J Vener Dis. 1973; 49: 531–535.PubMedGoogle Scholar
  22. 22.
    Vontver LA, Eschenbach DA. The role of Gardnerella vaginalis in nonspecific vaginitis. Clin Obstet Gynecol. 1981; 24: 439–460.PubMedCrossRefGoogle Scholar
  23. 23.
    Fleury FJ. Adult vaginitis. Clin Obstet Gynecol. 1981; 24: 407–438.PubMedCrossRefGoogle Scholar
  24. 24.
    Friedrich EG, Siegesmund KA. Tampon-associated vaginal ulcerations. Obstet Gynecol. 1980; 55: 149–156.PubMedGoogle Scholar
  25. 25.
    Oriel JD, Partridge BM, Denny MJ, et al. Genital yeast infections. Br Med J. 1972; 4: 761–764.PubMedCrossRefGoogle Scholar
  26. 26.
    Spellacy WN, Zaias N, Buhi WC, et al. Vaginal yeast growth and contraceptive practices. Obstet Gynecol. 1971; 38: 343–349.PubMedGoogle Scholar
  27. 27.
    Syverson RE, Buckley H, Gibian J, et al. Cellular and humoral immune status in women with chronic Candida infection. Am J Obstet Gynecol. 1979; 134: 624 - 627.PubMedGoogle Scholar
  28. 28.
    Proost JM, Maes-Dockx FM, Nelis MO, van Cutsem JM. Micronazole in the treatment of mycotic vulvovaginitis. Am J Obstet Gynecol. 1972; 112: 688–692.PubMedGoogle Scholar
  29. 29.
    Davis JE, Frudenfeld JH, Goddard JL. Comparative evaluation of monistat and mycostatin in the treatment of vulvovaginal candidiasis. Obstet Gynecol. 1974; 44: 403–406.PubMedGoogle Scholar
  30. 30.
    Culbertson C. Monistat: a new fungicide for treatment of vulvovaginal candidiasis. Am J Obstet Gynecol. 1974; 120: 973–976.PubMedGoogle Scholar
  31. 31.
    McNellis D, McLeon M, Lawson J, Pasquale SA. Treatment of vulvovaginitis candidiasis in pregnancy: a comparative study. Obstet Gynecol. 1977; 50: 674–678.PubMedGoogle Scholar
  32. 32.
    Robertson WH. Vulvovaginal candidiasis treated with clotrimazole cream in seven days with fourteen-day treatment with miconazole cream. Am J Obstet Gynecol. 1978; 132: 321–323.PubMedGoogle Scholar
  33. 33.
    Marks HJ. A double-blind comparison of clotrimazole and nystatin vaginal tablets in Candida vaginitis. Postgrad Med J. 1974; 50 (Suppl 1): 105–106.PubMedGoogle Scholar
  34. 34.
    Tan CG, Milne LJR, Good CS, Loudon JDO. A comparative trial of six-day therapy with clotrimazole and nystatin in pregnant patients with vaginal candidiasis. Postgrad Med J 1974; 50 (Suppl 1): 102–105.PubMedGoogle Scholar
  35. 35.
    Masterson G, Napier IR, Handerson JN, Roberts JE. Three-day clotrimazole treatment in candidal vulvovaginitis. Br J Vener Dis. 1977; 53: 126–128.Google Scholar
  36. 36.
    Brown D, Binder GL, Gardner HL, Wells J. Comparison of econazole and clotrimazole in the treatment of vulvovaginal candidiasis. Obstet Gynecol. 1980; 56: 121–123.PubMedGoogle Scholar
  37. 37.
    Swate TC, Weed JC. Boric acid treatment of vulvovaginal candidiasis. Obstet Gynecol. 1974; 43: 893–895.PubMedGoogle Scholar
  38. 38.
    Van Slyke KK, Michel VP, Rein MF. Treatment of vulvovaginal candidiasis with boric acid powder. Am J Obstet Gynecol. 1981; 141: 145–148.PubMedGoogle Scholar
  39. 39.
    Cooke CW. Vulvovaginal candidiasis (letter to editor). Obstet Gynecol. 1976; 48: 631.PubMedGoogle Scholar
  40. 40.
    Buck A, Christensen ES. Treatment of vaginal candidosis with natamycin and effect of treating the partner at the same time. Acta Obstet Gynecol Scand. 1982; 61: 393–396.CrossRefGoogle Scholar
  41. 41.
    Witkin SS, Yu IR, Ledger WJ. Inhibition of Candida albicans-induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am J Obstet Gynecol. 1983; 147: 809–811.PubMedGoogle Scholar
  42. 42.
    Horowitz BJ, Edelston SW, Lippman L. Sugar chromatography studies in recurrent Candida vulvovaginitis. J Reprod Med. 1984; 29: 441.PubMedGoogle Scholar
  43. 43.
    McCourtie J, Douglas LJ. Relationship between cell surface composition, adherence and virulence of Candida albicans. Infect Immun. 1984; 45: 6–12.PubMedGoogle Scholar
  44. 44.
    Peterson EA, Alling DW, Kirkpatrick CH. Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med. 1980; 93: 791–795.Google Scholar
  45. 45.
    Eschenbach DA, Hummel D. Recurrent and persistent vulvovaginal candidiasis: treatment with ketoconazole. Obstet Gynecol 1985; 66: 248–254.PubMedGoogle Scholar
  46. 46.
    Krieger JN. Urologie aspects of trichomoniasis. Invest Urol. 1981; 18: 411–417.PubMedGoogle Scholar
  47. 47.
    Block E. Occurrence of trichomonas in sexual partners of women with trichomoniasis. Acta Obstet Gynecol Scand. 1959; 38: 398–401.PubMedCrossRefGoogle Scholar
  48. 48.
    Weston TET, Nicol CS. Natural history of trichomonal infection in males. Br J Vener Dis. 1963; 39: 251–257.PubMedGoogle Scholar
  49. 49.
    Lossick JG. Treatment of Trichomonas vaginalis infections. Rev Infect Dis 1982; 4 (Suppl): S801–S818.CrossRefGoogle Scholar
  50. 50.
    Fouts AC, Kraus SJ. Trichomonas vaginalis: re-evaluation of its clinical presentation and laboratory diagnosis. J Infect Dis. 1980; 141: 137–143.PubMedCrossRefGoogle Scholar
  51. 51.
    Csonka GW: Trichomonas vaginitis treated with one dose of metronidazole. Br J Vener Dis. 1971; 47: 456–458.PubMedGoogle Scholar
  52. 52.
    Woodcock KR. Treatment of Trichomonas vaginalis with a single oral dose of metronidazole. Br J Vener Dis. 1972; 48: 65–68.PubMedGoogle Scholar
  53. 53.
    Underhill RA, Peck JE. Causes of therapeutic failure after treatment of trichomonal vaginitis with metronidazole: comparison of single-dose treatment with a standard regimen. Br J Clin Pract. 1974; 28: 134–136.PubMedGoogle Scholar
  54. 54.
    Hager WD, Brown ST, Kraus SJ, et al. Metronidazole for vaginal trichomoniasis. JAMA 1980; 244: 1219–1220.PubMedCrossRefGoogle Scholar
  55. 55.
    Aubert JM, Sesta HJ. Treatment of vaginal trichomoniasis: single 2 gram dose of metronidazole as compared with a seven-day course. J Reprod Med 1982; 27: 743–745.PubMedGoogle Scholar
  56. 56.
    Pereyra AJ, Lansing JD. Urogenital trichomoniasis: treatment with metronidazole in 2002 incarcerated women. Obstet Gynecol. 1964; 24: 499–508.PubMedGoogle Scholar
  57. 57.
    Lossick JG. Single-dose metronidazole treatment for vaginal trichomoniasis. Obstet Gynecol. 1980; 56: 508–510.PubMedGoogle Scholar
  58. 58.
    Lyng J, Christensen J. A double-blind study of the value of treatment with a single-dose tinidazole of partners to female with trichomoniasis. Acta Obstet Gynecol Scand. 1981; 60: 199–201.PubMedGoogle Scholar
  59. 59.
    Meingassner JG, Thurner J. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitromidazoles. Antimicrob Agents Chemother. 1979; 15: 254–257.PubMedGoogle Scholar
  60. 60.
    Lossick JG: Metronidazole (letter). N Engl J Med. 1981; 304: 735.PubMedGoogle Scholar
  61. 61.
    Rustia M, Shubik P. Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst. 1972; 48: 721–729.PubMedGoogle Scholar
  62. 62.
    Schnell JD. The incidence of vaginal candidiasis and trichomonas infections and treatment of trichomoniasis vaginitis with clotrimazole. Postgrad Med J. 1974; 50 (Suppl 1): 79–81.PubMedGoogle Scholar
  63. 63.
    Beard C, Noller K, O’Fallon W, et al. Lack of evidence for cancer due to use of metronidazole. N Engl J Med 1979; 301: 519–522.PubMedCrossRefGoogle Scholar
  64. 64.
    Spiegel CA, Amsel R, Eschenbach DA, et al. Anaerobic bacteria in nonspecific vaginitis. N Engl J Med 1980; 303: 601–606.PubMedCrossRefGoogle Scholar
  65. 65.
    Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis: diagnostic criteria and microbiolic and epidemiologic associations. Am J Med. 1983; 74: 14–22.PubMedCrossRefGoogle Scholar
  66. 66.
    Blackwell AL, Fox AR, Phillips I, Barlow D. An-aerobic vaginosis (nonspecific vaginitis): clinical microbiological and therapeutic findings. Lancet. 1982; 2: 1379–1382.Google Scholar
  67. 67.
    Spiegel CA, Eschenbach DA, Amsel R, Holmes KK. Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy. J Infect Dis. 1983; 148: 817–822.PubMedCrossRefGoogle Scholar
  68. 68.
    Amsel R, Critchlow CW, Spiegel CA, et al. Comparison of metronidazole, ampicillin and amoxicillin for treatment of bacterial vaginosis (nonspecific vaginitis): possible explanation for the greater efficacy of metronidazole. In: Feingold SM, ed. First United States Metronidazole Conference. New York: Biomed Information Corp., 1983: 224–237.Google Scholar
  69. 69.
    Eschenbach DA, Gravett MG, Chen KCS, Holmes KK. Complication of nonspecific bacterial vaginosis during pregnancy: An association with prematurity and postpartum complications. In eds: Mårdh PA, Taylor-Robinson D, eds. Bacterial vaginosis.Stockholm: Almquist & Wiksell, 1984;p. 213.Google Scholar
  70. 70.
    Eschenbach DA, Critchlow CW, Watkins H, et al. A dose duration study of metronidazole for treatment of nonspecific vaginitis. Scand J Infect Dis. 1983;Suppl 40: 73–80.Google Scholar
  71. 71.
    Baisdon MJ, Taylor GE, Pead L, Maskett R. Corynebacterium vaginalae and vaginitis: a controlled trial of treatment. Lancet. 1980; 1: 501–503.CrossRefGoogle Scholar
  72. 72.
    Alawattegama AB, Jones BM, Kinghorn GR, et al. Single dose versus seven day metronidazole in Gardnerella vaginalis associated nonspecific vaginitis (letter). Lancet. 1984; 1: 1355.PubMedCrossRefGoogle Scholar
  73. 73.
    Malouf M, Fortier M, Morin G, Dube J-L. Treatment of Haemophilus vaginalis vaginitis. Obstet Gynecol. 1981; 57: 711–714.PubMedGoogle Scholar
  74. 74.
    Minkowski WL, Baker CJ, Alleyne D, et al. Single oral dose metronidazole therapy for Gardnerella vaginalis vaginitis in adolescent females. J Adolesc Health Care. 1983; 4: 113–116.PubMedCrossRefGoogle Scholar
  75. 75.
    Purdon A, Hanna JH, Morse PL, et al. An evaluation of single-dose metronidazole treatment on Gardnerella vaginalis vaginitis. Obstet Gynecol. 1984; 64: 271–274.PubMedGoogle Scholar
  76. 76.
    Piot P, Van Dyck E, Godts P, Vanderheyden J. A placebo-controlled, double blind comparison of tinidazole and triple sulfonamide cream for the treatment of nonspecific vaginitis. Am J Obstet Gynecol 1983; 147: 85–89.PubMedGoogle Scholar
  77. 77.
    Lee L, Schmale JD: Ampicillin therapy for Corynebacterium vaginalae (.Haemophilus vaginalis) vaginitis. Am J Obstet Gynecol. 1973; 115: 786–788.PubMedGoogle Scholar
  78. 78.
    Rogers HA, Hesse FE, Pulley HD, et al. Haemophilus vaginalis (Corynebacterium vaginalae) vaginitis in women attending public health clin¬ics: response to treatment with ampicillin. Sex Trans Dis 1978; 5: 18 - 21.CrossRefGoogle Scholar
  79. 79.
    Durfee MA, Forsyth PS, Hale JA, Holmes KK: Ineffectiveness of erythromycin for treatment of Haemophilus vaginalis associated vaginitis: Possible relationship to acidity of vaginal secretion. Antimicrob Agent Chemother 1979; 16: 635–637.Google Scholar
  80. 80.
    Ralph ED, Amatnieks YE. Relative susceptibility of Gardnerella vaginalis (Haemophilus vaginalae), Neisseria gonorrhoeae and Bacteriodes fragilis to metronidazole and its two metabolites. Sex Transm Dis. 1980; 7: 157–160.PubMedCrossRefGoogle Scholar
  81. 81.
    Rees E, Tait I A, Hobson D, et al. Chlamydia in relation to cervical infection and pelvic inflammatory disease. In: Hobson D, Hoomes KK, eds. Washington, D.C.; Nongonococcal urethritis and related infections. American Society of Microbiology, 1977; 67–76.Google Scholar
  82. 82.
    Tam MR, Stamm WE, Handsfield HH, et al. Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med 1984; 310: 1146–1150.PubMedCrossRefGoogle Scholar
  83. 83.
    Scheffy LC, Rakoff AE, Lang WR. An unusual case of exudative vaginitis (hydrorrhea vaginalis) treated with local hydrocortisone. Am J Obstet Gynecol 1956; 72: 208.Google Scholar
  84. 84.
    Purola E, Savia E. Cytology of gynecologic condyloma acuminata. Acta Cytol. 1977; 21: 26–31.PubMedGoogle Scholar
  85. 85.
    Oriel JD. Natural history of genital warts. Br J Vener Dis. 1971; 47: 1–13.PubMedGoogle Scholar
  86. 86.
    Gardner HL. Nonvenereal bacterial vulvovaginitides. In: Gardner HL, Kaufman RH, eds. Benign diseases of the vulva and vagina. Boston: GK Hall Medical Publ, 1981; p 303.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1986

Authors and Affiliations

  • David A. Eschenbach

There are no affiliations available

Personalised recommendations